VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > And so it starts

<< Previous

Bullboard Posts

Next >>

Comment by Xwing229on Sep 24, 2020 10:49am

149 Views

Post# 31611129

RE:RE:RE:RE:And so it starts

70-100 is perfectly achievable but not overnight. Each hospital buying one is a potential multi-units order once the staff gets used to it. TAM is 40k, I see no reason why they can't ramp up to 100 by the end of 2021

<< Previous

Bullboard Posts

Next >>

Canadians having more difficulty saving for retirement, study finds